Zelalem Eshete

Array ( [id] => 4698903 [patent_doc_number] => 20080221087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Substituted lactams as inhibitors of abeta protein production' [patent_app_type] => utility [patent_app_number] => 11/788708 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34890 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221087.pdf [firstpage_image] =>[orig_patent_app_number] => 11788708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5225603 [patent_doc_number] => 20070254870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Compounds, compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/788784 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18400 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254870.pdf [firstpage_image] =>[orig_patent_app_number] => 11788784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693232 [patent_doc_number] => 20080086003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'Crystalline Compounds' [patent_app_type] => utility [patent_app_number] => 11/734520 [patent_app_country] => US [patent_app_date] => 2007-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17133 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20080086003.pdf [firstpage_image] =>[orig_patent_app_number] => 11734520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564944 [patent_doc_number] => 20090137797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/296969 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6164 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137797.pdf [firstpage_image] =>[orig_patent_app_number] => 12296969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410900 [patent_doc_number] => 20090124799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Process for the preparation of Caprolactam Cgrp Antagonist' [patent_app_type] => utility [patent_app_number] => 12/226113 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10111 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124799.pdf [firstpage_image] =>[orig_patent_app_number] => 12226113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574595 [patent_doc_number] => 07829699 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-09 [patent_title] => 'Process for the preparation of CGRP antagonist' [patent_app_type] => utility [patent_app_number] => 12/226244 [patent_app_country] => US [patent_app_date] => 2007-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9619 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/829/07829699.pdf [firstpage_image] =>[orig_patent_app_number] => 12226244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368808 [patent_doc_number] => 20090306367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'PROCESS FOR PREPARING AMIDES FROM KETOXIMES' [patent_app_type] => utility [patent_app_number] => 12/296498 [patent_app_country] => US [patent_app_date] => 2007-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3056 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306367.pdf [firstpage_image] =>[orig_patent_app_number] => 12296498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5304152 [patent_doc_number] => 20090298804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Novel Compounds and Methods for Their Production' [patent_app_type] => utility [patent_app_number] => 12/294267 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17530 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298804.pdf [firstpage_image] =>[orig_patent_app_number] => 12294267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5264442 [patent_doc_number] => 20090117127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-07 [patent_title] => 'Novel Compounds and Methods for Their Production' [patent_app_type] => utility [patent_app_number] => 12/294099 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21048 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20090117127.pdf [firstpage_image] =>[orig_patent_app_number] => 12294099 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5160600 [patent_doc_number] => 20070173644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-26 [patent_title] => 'PROCESS FOR THE PREPARATION OF MFI-TYPE ZEOLITIC CATALYSTS' [patent_app_type] => utility [patent_app_number] => 11/693072 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6499 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20070173644.pdf [firstpage_image] =>[orig_patent_app_number] => 11693072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5422988 [patent_doc_number] => 20090149443 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'P38 INHIBITORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/294550 [patent_app_country] => US [patent_app_date] => 2007-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28947 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149443.pdf [firstpage_image] =>[orig_patent_app_number] => 12294550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4939426 [patent_doc_number] => 20080076745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'ANTIBACTERIAL AMIDE MACROCYCLES IV' [patent_app_type] => utility [patent_app_number] => 11/690762 [patent_app_country] => US [patent_app_date] => 2007-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54795 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076745.pdf [firstpage_image] =>[orig_patent_app_number] => 11690762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800407 [patent_doc_number] => 07425551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Malonamide derivatives' [patent_app_type] => utility [patent_app_number] => 11/726639 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15406 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425551.pdf [firstpage_image] =>[orig_patent_app_number] => 11726639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063867 [patent_doc_number] => 20070225508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Transformation of tricyclopentabenzene (trindane) to 12 - hydroxy - 16 - oxatetracyclo [10.3.1.01.5.07.11] hexadec -7(11) - en -2,6-dione' [patent_app_type] => utility [patent_app_number] => 11/725569 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1342 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225508.pdf [firstpage_image] =>[orig_patent_app_number] => 11725569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588051 [patent_doc_number] => 07439237 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions' [patent_app_type] => utility [patent_app_number] => 11/688123 [patent_app_country] => US [patent_app_date] => 2007-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14484 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 848 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439237.pdf [firstpage_image] =>[orig_patent_app_number] => 11688123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063632 [patent_doc_number] => 20070225272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/724066 [patent_app_country] => US [patent_app_date] => 2007-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36892 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225272.pdf [firstpage_image] =>[orig_patent_app_number] => 11724066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369891 [patent_doc_number] => 07476664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Bis-2-difluoro-pyrrolo[2,1-C][1,4]benzodiazepine dimers' [patent_app_type] => utility [patent_app_number] => 11/715592 [patent_app_country] => US [patent_app_date] => 2007-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4333 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476664.pdf [firstpage_image] =>[orig_patent_app_number] => 11715592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 81900 [patent_doc_number] => 07745457 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Meridamycin analogues for the treatment of neurodegenerative disorders' [patent_app_type] => utility [patent_app_number] => 11/713972 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6250 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745457.pdf [firstpage_image] =>[orig_patent_app_number] => 11713972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 225073 [patent_doc_number] => 07605257 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-20 [patent_title] => 'Processes for preparing water-soluble polyethylene glycol conjugates of macrolide immunosuppressants' [patent_app_type] => utility [patent_app_number] => 11/713973 [patent_app_country] => US [patent_app_date] => 2007-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5990 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/605/07605257.pdf [firstpage_image] =>[orig_patent_app_number] => 11713973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441989 [patent_doc_number] => 20090093628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Process for Production of Amides or Lactams' [patent_app_type] => utility [patent_app_number] => 12/224660 [patent_app_country] => US [patent_app_date] => 2007-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8437 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093628.pdf [firstpage_image] =>[orig_patent_app_number] => 12224660 [rel_patent_id] =>[rel_patent_doc_number] =>)